drugset / Trial / NCT00805558

Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole on Patients With Chronic Periodontitis

NCT00805558

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the clinical and microbiological effectiveness of the moxifloxacin compared with the combination ciprofloxacin - metronidazole, when used as adjunctive therapy to scaling and root planning for the treatment of advanced chronic periodontitis.

Timeline

Start
2009-02
Primary completion
2009-12
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciprofloxacin Small molecule 1000 mg
Comparator Metronidazole Small molecule 500 mg
Subject Moxifloxacin Small molecule 400 mg

Indications